Goldman Sachs’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.8M | Buy |
|
|||||
|
2025
Q1 | $11.4M | Sell |
|
|||||
|
2024
Q4 | $17M | Buy |
|
|||||
|
2024
Q3 | $12.3M | Sell |
|
|||||
|
2024
Q2 | $13.7M | Buy |
|
|||||
|
2024
Q1 | $7.08M | Sell |
|
|||||
|
2023
Q4 | $8.76M | Buy |
|
|||||
|
2023
Q3 | $6.62M | Sell |
|
|||||
|
2023
Q2 | $11.2M | Sell |
|
|||||
|
2023
Q1 | $10.7M | Buy |
|
|||||
|
2022
Q4 | $6.01M | Sell |
|
|||||
|
2022
Q3 | $7.33M | Buy |
|
|||||
|
2022
Q2 | $3.33M | Buy |
|
|||||
|
2022
Q1 | $3.1M | Buy |
|
|||||
|
2021
Q4 | $2M | Sell |
|
|||||
|
2021
Q3 | $2.09M | Buy |
|
|||||
|
2021
Q2 | $806K | Buy |
|
|||||
|
2021
Q1 | $457K | Buy |
|
|||||
|
2020
Q4 | $321K | Sell |
|
|||||
|
2020
Q3 | $1.29M | Buy |
|